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Although multiple studies have documented the expression of over 70 novel virus-encoded microRNAs (miRNAs), the
targets and functions of most of these regulatory RNA species are unknown. In this study a comparative bioinformatics
approachwasemployedtoidentifypotentialhumancytomegalovirus(HCMV)mRNAtargetsofthevirus-encodedmiRNA
miR-UL112-1. Bioinformatics analysis of the known HCMV mRNA 39 untranslated regions (UTRs) revealed 14 potential
viral transcripts that were predicted to contain functional target sites for miR-UL112-1. The potential target sites were
screened using luciferase reporters that contain the HCMV 39UTRs in co-transfection assays with miR-UL112-1. Three of
the 14 HCMV miRNA targets were validated, including the major immediate early gene encoding IE72 (UL123, IE1),
UL112/113, andUL120/121. Further analysisof IE72regulation bymiR-UL112-1 with clones encodingthecompletemajor
immediate early region revealed that the IE72 39UTR target site is necessary and sufficient to direct miR-UL112-1-specific
inhibition of expression in transfected cells. In addition, miR-UL112-1 regulation is mediated through translational
inhibition rather than RNA degradation. Premature expression of miR-UL112-1 during HCMV infection resulted in a
significantdecreaseingenomicviralDNAlevels,suggestingafunctionalroleformiR-UL112-1inregulatingtheexpression
ofgenesinvolvedinviralreplication.ThisstudydemonstratestheabilityofaviralmiRNAtoregulatemultipleviralgenes.
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Introduction
microRNAs (miRNAs) are a species of regulatory RNA
molecules that are involved in the control of a variety of
cellular processes [1–3]. miRNAs are small single-stranded
RNA species of approximately 20–24 bases in length and are
initially expressed in the nucleus, where they form deﬁned
hairpin loop structures within longer primary transcripts [4].
The hairpin loop sequence containing the miRNA is
recognized and cleaved by the RNAseIII Drosha complex [5]
and transported to the cytoplasm by exportin 5 [6,7].
Additional processing by a second endonuclease, Dicer,
produces a double-stranded RNA from which one strand is
loaded into the RNA-induced silencing complex [8–11].
Targeting of transcripts by the miRNA RNA-induced silenc-
ing complex relies on complementarity between the miRNA
and the target transcript. In cases of complete homology, the
target transcript is cleaved, while partial homology can lead
to RNA cleavage or translational inhibition [12–14]. The
precise nucleotide requirements for functional binding of a
miRNA to a target sequence are not fully understood.
However, binding within the ﬁrst 10 bases of a miRNA,
especially within bases 2 to 7 of the miRNA known as the seed
region, is considered particularly important [15–17].
miRNAs are ubiquitous among multicellular eukaryotic
organisms and have been identiﬁed in species as diverse as
plants and higher mammals [15]. The expression of miRNAs is
also a phenomenon common to many DNA viruses [18], and
bioinformatic and direct cloning approaches have led to the
identiﬁcation of over 70 novel miRNAs expressed in DNA
viruses [19]. The majority of these viral miRNAs have been
identiﬁed in the herpesvirus family, although SV40 and
adenoviruses also encode their own miRNAs [20–33]. Her-
pesviruses belong to a large family of enveloped, double-
stranded DNA viruses disseminated throughout nature that
are able to maintain a persistent or latent infection during
the lifetime of the host [34]. The herpesviruses are divided
into three groups (alpha, beta, and gamma), and members of
all three groups encode miRNAs, indicating that herpesvi-
ruses have utilized RNA interference (RNAi) throughout their
evolution. miRNAs identiﬁed in a- and c-herpesviruses are
located within clusters in and around genomic regions
associated with latent transcription. Three a-herpesviruses,
herpes simplex virus-1 (HSV-1) and Marek disease virus-1 and
2 (MDV-1 and MDV-2), have been shown to encode miRNAs
close to and within the minor latency-associated transcript, a
non-coding RNA detected during latent infections of all three
viruses [20,21,24,27]. Multiple miRNAs have been identiﬁed
within two genomic regions of the c-herpesvirus Epstein–
Barr virus and are expressed during latent infection of
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68 (MHV-68), tRNA-like transcripts previously identiﬁed as
latency markers were found to encode a number of miRNAs,
whereas the majority of the miRNAs expressed by Kaposi
sarcoma-associated herpesvirus (KSHV) are processed from a
single transcript also associated with latent gene expression
[29]. In contrast to a and c herpesviruses, miRNAs encoded by
the b-herpesvirus human cytomegalovirus (HCMV) are
located throughout the genome and were identiﬁed and
detected during acute infection [25,26,29]. Following infec-
tion of human ﬁbroblast cells, HCMV miRNAs accumulate as
the infection progresses and in the majority of cases are
expressed with early kinetics. Of the nine miRNAs encoded
by HCMV, four are encoded antisense to open reading frames
(ORFs), with the remaining encoded within intergenic
regions, including UL36–1, which is encoded within the
intron of the anti-apoptosis gene UL36 [35].
Validated target transcripts and regulatory functions for
the vast majority of viral miRNAs remain unknown. Two
likely scenarios for viral miRNA function include targeting of
cellular gene expression to induce a more favorable environ-
ment for the virus, or the regulation of viral genes to establish
precise temporal or tissue-speciﬁc regulation of viral gene
expression. To date, viral miRNAs do not demonstrate
complete homology to any known cellular transcript,
suggesting that targeting of cellular genes is unlikely to occur
through direct cleavage. Two recent reports have suggested
that cellular genes can be regulated through incomplete
binding of viral miRNAs to target sequences within cellular
39UTRs. Gupta et al. identiﬁed a miRNA encoded by HSV-1,
which the authors suggest protects infected cells against
apoptosis by inhibiting the translation of the cellular genes,
TGF-b1 and SMAD3 [27]. In addition, Samols et al. identiﬁed
the cellular gene THBS-1 as a target for KSHV miRNAs [36].
Surprisingly, the authors found that all ten of the KSHV
miRNAs targeted this gene, suggesting a remarkably high
level of redundancy. Viral miRNAs have also been reported to
regulate expression of viral genes. SV40 regulates the
expression of its large T antigen via two miRNAs encoded
directly antisense to the gene [33]. Expression of the miRNAs
leads to cleavage of the large T antigen transcript and
reduced levels of large T antigen during infection. There are,
however, no reports of trans-regulation of viral gene
expression by viral miRNAs through binding to target
sequences with incomplete homology.
The aim of the current study was to identify and
characterize functional targets of the HCMV-encoded miR-
NA miR-UL112-1. Using a bioinformatics approach in
combination with luciferase assays, we identiﬁed three HCMV
gene targets for miR-UL112-1, including the mRNA encoding
the major immediate early (MIE) trans-activating protein
IE72. IE72, and the additional MIE transactivator, IE86, are
the most abundant transcripts expressed from the complex
MIE region of the viral genome, are known to be critical for
the induction of early and late gene expression, and are
required for efﬁcient viral replication [37]. These studies
provide the ﬁrst description to our knowledge of a viral
miRNA that regulates multiple viral genes through binding to
the 39 untranslated region (UTR) of viral transcripts and
inhibition of translation.
Results
miR-UL112-1 Negatively Regulates Expression
from Vectors Containing the HCMV 39UTRs of
IE72, UL112/113, and UL120/121
To determine whether miR-UL112-1 targets HCMV genes,
we used a bioinformatics approach to predict potential
miRNA binding sites within the 39UTRs of HCMV transcripts.
Currently, there is limited data available regarding the
precise 39 ends of HCMV transcripts. Therefore, we estab-
lished a putative 39UTR database by including sequences
from the 39 end of each annotated ORF to the ﬁrst canonical
AATAAA polyadenylation signal following that 39 end. Using
the online miRNA target identiﬁcation algorithm RNAhybrid
[38], the 39UTR database was searched for potential miR-
UL112-1 target sites. Thirty-two unique target sites for miR-
UL112-1 were identiﬁed in 37 different HCMV ORFs. The
total number of sites increased to 63 when we included
repeated sites within overlapping 39UTRs of neighboring
ORFs. To further reﬁne this approach, we also predicted
target sites for the closely related chimpanzee cytomegalovi-
rus (CCMV) in a parallel manner. Since miRNAs encoded by
HCMV are highly conserved in CCMV and in the case of miR-
UL112-1 the sequences are identical between the two viruses,
we predicted that miR-UL112-1 would target the same
transcripts in both HCMV and CCMV. Therefore, miRNA
target sites conserved within similar 39UTR sequences have a
higher probability of being functional. Following analysis of
the CCMV genome, 34 39UTRs were predicted to contain
target sites for miR-UL112-1 with 14 39UTRs containing
target sites in both HCMV and CCMV (Figure 1). A list of the
14 identiﬁed genes, along with a brief description of their
functions, if known, is shown in Table S1 [39].
To determine whether the predicted target sequences
represent functional target sites for miR-UL112-1, each of the
sequences was cloned at the 39 end of the luciferase reporter
construct in pMIR (Ambion). When the 39UTR sequence was
too large to clone in its entirety, the target sequence along
with 500 bases of ﬂanking sequence was used. If neighboring
39UTR sequences contained overlapping target sites, a single
representative sequence containing the targets was used.
Nucleotide coordinates of the cloned regions are listed in the
Materials and Methods section. To express miR-UL112-1, the
predicted coding sequence for miR-UL112-1 pre-miR was
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Author Summary
Our ability to understand the biology of viruses depends not only on
functional analysis of genes they encoded but also on specific
regulation of those genes during viral infection. In herpesviruses,
viral gene regulation is highly complex and plays a significant role in
determining the viral life cycle during acute, latent, or persistent
infection. The discovery that many herpesviruses express small
regulatory RNAs, known as microRNAs, has opened up a whole new
area of research in regulation of gene expression. In this paper we
demonstrate that a microRNA expressed by human cytomegalovirus
is able to regulate multiple viral genes, including one gene thought
to be crucial for both acute and latent stages of viral infection in the
host. Expression of this microRNA results in a significant reduction in
viral replication. This work therefore demonstrates that viral
microRNAs can regulate multiple viral genes and can have
significant effects on the replication of a virus.cloned into the vector pSIREN (Clontech) and expression of
mature miR-UL112-1 was conﬁrmed by northern analysis
(Figure S1). 39UTR constructs were co-transfected with either
pSIREN miR-UL112-1 or the same vector expressing a
randomized negative hairpin RNA supplied with the pSIREN
plasmid. As shown in Figure 2, three out of the 14 luciferase
constructs containing potential HCMV 39UTR miR-UL112-1
target sequences, IE72, UL120/121, and UL112/113, directed
speciﬁc inhibition of luciferase activity in the presence of
miR-UL112-1. These observations demonstrate that these
three HCMV 39 UTR sequences are functional miR-UL112-1
target sites (Figure 2A). Schematic representations of pre-
dicted mir-UL112-1 binding to the Ul112/113 and UL120/121
and IE72 target sequences are shown in Figure 2B.
The identiﬁcation of functional target sites clustered
within the 39UTRs of the MIE region of the virus was
particularly interesting. One site was identiﬁed within the
39UTR of UL123, which encodes IE72, with two overlapping
sites within the 39UTR of ORFs UL120 and UL121 (Figure 3).
Intriguingly, the site downstream of IE72 of CCMV main-
tained less homology to miR-UL112-1 than the equivalent site
in HCMV, and would presumably form a less effective
binding site. However, a second site was identiﬁed further
upstream that was not found in the HCMV counterpart,
suggesting that CCMV has evolved two less effective binding
sites in comparison to the more homologous single site found
in HCMV (Figure S2A and S2B). Interestingly, both IE72 and
UL112/113 encode gene products important for viral repli-
cation, and although the function of UL120/121 is unknown,
it has been suggested that UL120/121 may encode exons
within the MIE family of transcripts [40].
Expression of IE72 Protein Is Specifically Inhibited
by miR-UL112-1
Since IE72 serves an important regulatory role during
HCMV replication, we examined the regulation of this
immediate early (IE) gene product by miR-UL112-1 in more
detail. To conﬁrm that miR-UL112-1-mediated inhibition of
luciferaseactivityinthepresenceoftheIE7239UTRwasdueto
the predicted target site, a deletion mutation encompassing
the 39 half of the target (Figure 4A) was analyzed for luciferase
activity. The deletion mutation completely abrogated the
inhibitoryeffectofmiR-UL112-1(Figure4B).Expressionofthe
HCMV miRNA miR-UL22A-1, which is not predicted to target
IE72, caused only a minor reduction in luciferase activity, and
miR-UL112-1 also did not target a construct containing the
39UTR of IE86 (unpublished data). These results indicate that
miR-UL112-1 regulation of IE72 is speciﬁc and requires the
predicted target sequence identiﬁed in the 39UTR.
Following conﬁrmation of the speciﬁc regulation of a
reporter construct containing the IE72 39UTR, we examined
the effect of miR-UL112-1 on IE72 protein expression in the
contextoftheHCMVgenomicclonepSVH-1[41]thatencodes
the complete IE region, including the MIE promoter driving
expression of IE72 and IE86.In these experiments pSVH-1 was
co-transfected with either pSIREN miR-UL112-1 or the
control plasmid pSIREN UL22A-1 into 293 cells. IE86
expression provides an ideal control since expression of this
IE protein is regulated by the same promoter as IE72, but the
IE86 39 UTR does not contain the miR-UL112-1 target
sequence. Total cellular protein was extracted at 24, 48, and
72 h post transfection and examined by western blot analysis
using a polyclonal antibody that recognizes both IE72 and
IE86. As shown in Figure 4C, co-expression of miR-UL112-1 in
the context of pSVH-1 signiﬁcantly reduced the levels of IE72,
but not IE86, expression in comparison to a vector expressing
a miRNA not targeting this 39UTR. These observations are
consistent with the luciferase results, suggesting that the
negative regulatory effects of miR-UL112-1 are speciﬁc to
messenger RNAs containing the predicted miRNA target site.
However, the level of IE72 reduction was much greater than in
theluciferasereporterexperiments,withadecreaseinprotein
expression of approximately 14-fold as determined by
densitometry (Figure 4D). This difference may reﬂect inherent
variations in the assays or more effective inhibition of the
endogenous IE72 viral transcript compared to the artiﬁcial
luciferase reporter transcript. In addition, the inhibitory
effects of miR-UL112-1 were not observed using a pSVH-1
construct deleted for the target sequence (Figure 4C and 4D).
Additional smaller mutations within the target region also
disrupted the inhibitory effect of miR-UL112-1, including
mutations within the seed sequence (Figure S3). Interestingly,
point mutations that introduced G:U base pairing within the
seed region did not disrupt the inhibitory effects of miR-
UL112-1, which is consistent with recent data [42] indicating
that Watson and Crick base pairing within the seed region is
not essential for target function (Figure S3).
Recent studies have suggested that degradation of target
transcripts may occur even if the target site contains only
partial homology to the miRNA. Degradation is thought to
occur through the accumulation of miRNA-targeted tran-
scripts in proximity to cytoplasmic RNA processing regions
called P bodies [43–45]. To determine whether the reduction
in IE72 levels following expression of miR-UL112-1 was due
to translational inhibition, or the result of mRNA degrada-
tion, IE72 and IE86 transcript levels were determined by
reverse transcriptase (RT)-PCR following co-transfection of
pSIREN UL112–1 with pSVH-1 or the pSVH-1 deletion
Figure 1. Bioinformatic Strategy for the Identification of miR-UL112-1
Targets in HCMV Genome
39UTR sequences were determined as the 39 end of each annotated ORF
to the first AATAAA polyadenylation site. Following analysis using
RNAhybrid, 14 candidate 39UTRs contained target sites for miR-UL112-1
were identified within corresponding HCMV and CCMV 39UTR sequences.
doi:10.1371/journal.ppat.0030163.g001
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unaffected by miR-UL112-1 expression, indicating that the
reduction in IE72 protein levels occurs primarily through a
post-transcriptional mechanism.
Finally, to determine whether the predicted IE72 target
sequence was sufﬁcient to direct inhibition of gene
expression through miR-UL112-1, the predicted 21-base
target sequence was introduced into the 39UTR of IE86 in
the IE72 target deletion background of pSVH-1. As shown in
Figure 4F, expression of miR-UL112-1 led to a reduction in
IE86 protein levels, although not to the same degree
previously shown with IE72. This suggests that complete
function of the target sequence may require additional
ﬂanking sequences. Thus, we have demonstrated that in the
context of either a luciferase reporter construct containing
the IE72 39UTR or with a genomic expression vector
containing the complete MIE region, miR-UL112-1 speciﬁ-
cally targets the expression of IE72 through a conserved
target site within the IE1 39UTR. The target site is necessary
and sufﬁcient to direct miR-UL112-1 speciﬁc inhibition of
expression, and this effect occurs through translational
inhibition rather than degradation of the transcript.
Pre-Expression of miR-UL112-1 Reduces Both
IE72 Expression and Viral DNA Replication
Although the effect of miR-UL112-1 on the down regulation
of IE72 expression from a genomic vector is clear, the
importance of this inhibition during viral infection is
unknown. We have previously shown that during the early
stagesofHCMVinfection,whenIE72expressionlevelsarehigh,
Figure 2. Luciferase Screening of HCMV 39UTR Candidate Sequences
(A) Luciferase screening of HCMV 39UTR candidate sequences. Predicted target sequences were tested for their ability to inhibit expression of a
luciferase reporter construct in the presence of miR-UL112-1. Either the entire 39UTR (in the case of IE72, UL112/113 and UL120) or the predicted target
sequence within 500 bases of flanking sequence were cloned downstream of the luciferase reporter gene and co-transfected with either a miR-UL112-1
expression plasmid or the same expression plasmid containing a random hairpin sequence as a negative control (pSIREN Neg). Results are shown as
percentage expression of negative control sample following correction for transfection levels according to control renilla luciferase expression. Each
transfection was carried out in duplicate.
(B) Predicted miR-UL112-1 binding to functional target sites determined using mfold algorithm [60]. Seed region indicated by box surrounding
nucleotide 2–6 of miRNA/target.
doi:10.1371/journal.ppat.0030163.g002
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to signiﬁcant levels until late in infection [26]. Furthermore,
previous studies have demonstrated that disruption of IE72
expression decreases efﬁcient viral replication at low multi-
plicities of infection [46,47]. Therefore, we predicted that
expression of miR-UL112-1 prior to infection with HCMV
would lead to a block in IE72 expression, potentially leading to
disruption of efﬁcient HCMV replication.
To determine the effect of pre-expressing miR-UL112-1 on
production of IE72 as well as on viral DNA replication during
infection, we used a commercially produced synthetic miR-
UL112-1: a short double-stranded RNA with the exact
sequence of mature endogenous miR-UL112-1. To ﬁrst
demonstrate that the synthetic miR-UL112-1 can inhibit
IE72 expression as effectively as the pSIREN miR-UL112-1
construct, U373 cells were co-transfected with pSVH-1 and
either synthetic miR-UL112-1 or a random sequence negative
control pre-miR (Ambion). As shown in Figure S4, synthetic
miR-UL112-1 RNA effectively inhibits IE72 expression.
We next determined whether transfection of U373 with
synthetic miR-UL112-1 RNA cells prior to infection with
HCMV could effectively block IE72 expression. U373 cells
were therefore transfected with either the synthetic miR-
UL112-1 or the negative control RNA followed by infection
with an AD169 strain containing an eIF1-a driven green
ﬂuorescent protein (gfp) cassette inserted into the UL21.5
gene. Cells were infected at a multiplicity of 0.5 plaque-
forming units per cell. Total protein was harvested between
24 and 72 h post infection, and levels of viral immediate early
proteins were determined through western blot analysis using
a polyclonal antibody that recognizes IE72, IE86, and two
other products of the MIE region. As seen in Figure 5A, miR-
UL112-1 signiﬁcantly inhibited the expression of IE72.
However, additional proteins encoded by the IE region were
also decreased in expression. This result is in contrast with
the speciﬁc regulation of IE72 observed following trans-
fection with pSVH-1 and does not reﬂect the phenotype
observed for IE72 knock-out viruses. This observation is not
entirely surprising, as we have previously shown that two
additional viral genes other than IE72 contain functional
target sites for miR-UL112-1. We also predict that other viral
targets exist that were not identiﬁed through our bioinfor-
matics screen. Expression of miR-UL112-1 is therefore likely
to have pleiotropic effects on viral infection, resulting in a
phenotype distinct from IE72 knock-out viruses. Targeting of
IE72 by miR-UL112-1 therefore likely contributes to the
phenotypic effects shown in this report, but is unlikely to be
the only factor involved.
An attenuation of viral replication caused by an inhibition
of IE72 expression may also contribute to a global reduction
in viral gene expression due to decreased levels of viral
template. Consistent with this model, the levels of gfp
ﬂuorescence expressed by the virus were signiﬁcantly reduced
in cells transfected with synthetic miR-UL112-1 (Figure 5B),
suggesting attenuation in viral replication or infection. To
conﬁrm whether transfection of miR-UL112-1 results in a
reduction in the efﬁciency of viral replication, viral DNA
levels were analyzed by real-time PCR. Viral DNA levels were
consistently lower in cells transfected with miR-UL112-1 than
in control cells at later time points, indicating that the miR-
UL112-1 has a signiﬁcant negative effect on acute replication
of the virus (Figure 5C). Importantly, transfection of cells with
miR-UL112-1 had no effect on DNA replication of HSV-1,
indicating that the reduction in HCMV DNA replication
caused by miR-UL112-1 is not due to a general attenuation of
DNA viral replication (Figure 5D). Together, these results
demonstrate that pre-expression of miR-UL112-1 has pleio-
tropic effects on HCMV and that this regulation can inhibit
viral DNA replication.
Discussion
In this study, we demonstrate that a viral miRNA is capable
of regulating multiple viral genes through partially homolo-
gous target sites within the 39UTR regions of viral transcripts.
In the case of IE72, regulation occurs post-transcriptionally
and is dependent on a sequence within the 39UTR of the
mRNA. Transfection of cells with a synthetic miR-UL112-
1RNA prior to infection results in a signiﬁcant reduction in
IE72 expression and downstream effects on the expression of
other proteins encoded by the MIE region. Further potential
targets include UL112/113, which encodes proteins involved
in promoting viral DNA synthesis [48], and the ORFs UL120
and UL121, which are directly downstream of the IE86 ORF
and may represent exons within the MIE region. The fact that
these transcripts contain target sites in both HCMV and
Figure 3. Genomic Position of miR-UL112-1 Targets Sites within the MIE Region
The MIE region showing IE72 and IE86 transcripts resulting from alternative splicing are shown as well as splicing to downstream exons UL120/UL121.
Position of miR-UL112-1 target sites in 39UTR region of IE72 and UL120/UL121 indicated by red boxes.
doi:10.1371/journal.ppat.0030163.g003
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by miR-UL112-1 is evolutionarily conserved. We hypothesize
that targeting of multiple viral transcripts by this miRNA
would have signiﬁcant effects on viral replication.
Functional Role of IE72 in HCMV Infection
The MIE region of HCMV is known to express a number of
regulatory proteins crucial for the efﬁcient replication of the
virus and coordination of viral gene expression. Although
driven by the same promoter, differential splicing leads to the
expression of multiple transcripts and proteins. The most
abundant of these proteins are the major trans-activators IE72
and IE86, which are expressed from ﬁve exons within the MIE
region. The ﬁrst three exons are common to both transcripts,
with differential splicing resulting in the fourth exon
encoding IE72, and the ﬁfth exon encoding IE86 [49–51].
Figure 4. miR-UL112-1 Specifically Inhibits IE72 Protein Expression but Not mRNA Transcription
(A) 39UTR sequence of IE72 indicating predicted target sequence shown in red and the underlined region deleted in pSVH-1 deletion.
(B) Luciferase construct containing either the IE72 39UTR or the IE72 39UTR deleted for miR-UL112-1 target sequence or luciferase construct containing
the IE86 39UTR were co-transfected with pSIREN miR-UL112-1 or the control pSIREN expressing miR-UL22A-1. Luciferase levels only inhibited in
construct containing full IE72 39UTR in the context of miR-UL112-1 expression.
(C) IE72 and IE86 protein levels determined following co-transfection with genomic plasmid, pSVH-1, containing IE72 and IE86 exons and miR-UL112-1
expression plasmid or miR-UL22A-1 expression plasmid. miR-UL112-1 significantly reduces IE72 expression levels but not IE86 levels. The pSVH-1
plasmid containing deletion mutation depicted in Figure 4A was unaffected by miR-UL112-1 expression.
(D) Densitometry analysis of western blot depicted in Figure 4C.
(E) IE72 and IE86 RNA levels were determined by RT-PCR following co-transfection of pSVH-1 or pSVH-1 deletion with pSIREN miR-UL112-1 using
primers that span intronic regions. IE72 and IE86 RNA levels were unaffected despite inhibition of IE72 protein expression in pSVH-1 construct,
indicating the mechanism is post-transcriptional. Reactions that did not include RT enzyme showed no detectable signal.
(F) Insertion of predicted target sequence into 39UTR of IE86 directs miR-UL112-1-dependent inhibition, indicating the predicted sequence is
functionally sufficient.
doi:10.1371/journal.ppat.0030163.g004
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Regulation of Viral Genes by HCMV-Encoded microRNAsFigure 5. miR-UL112-1 Inhibits Immediate Early Gene Expression and Viral DNA Replication
U373 cells were transfected with either synthetic miR-UL112-1 or a random sequence negative pre-miR RNA followed by infection with AD169gfp at a
multiplicity of 0.5 plaque-forming units per cell.
(A) Total protein was harvested and analyzed by western blot using an antibody that cross reacts with MIE genes. miR-UL112-1 transfection resulted in
significant reduction in immediate early gene expression.
(B) Levels of gfp were determined by microscopy at 24 and 48 h post infection, demonstrating a reduction in gfp fluorescence in cells transfected with
miR-UL112-1 at later time points.
(C) DNA was isolated from infected cells at the indicated time points and viral DNA levels were determined by real-time PCR and corrected against beta-
actin copies. Transfection of miR-UL112-1 (syn miR-UL112-1) results in consistently lower levels of HCMV DNA at later time points compared to cells
transfected with randomized control miRNA (syn negative).
(D) DNA replication of HSV-1 is unaffected by miR-UL112-1 expression. U373 Cells were transfected with either miR-UL112-1 or the negative control RNA
and infected with HSV at a multiplicity of 0.1. DNA levels were determined by PCR and corrected against beta-actin copies.
doi:10.1371/journal.ppat.0030163.g005
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individual 39UTRs, which results in speciﬁc regulation of IE72
by miR-UL112-1 and may contribute to the independent
expression kinetics of IE72 and IE86. Both proteins are
thought to be important in promoting early and late viral
transcription, although only IE86 is essential for virus
replication [41,46,47,52,53]. However, disruption of IE72
expression results in a signiﬁcant attenuation of viral
replication following low multiplicity infections [46].
Although the precise mechanism of action of IE72 is not
fully understood, it is thought that the viral protein promotes
transcription through interaction with cellular factors.
Studies have shown that IE72 causes disruption of ND10
domains within the nucleus [54,55] and can directly interact
with cellular basal transcription factors [56].
Role of IE72 Regulation by miR-UL112-1
during HCMV Infection
The functional relevance of IE72 regulation by miR-UL112-
1 is currently unclear, but this mechanism could affect viral
replication in one of several ways. Expression of IE72 is down
regulated late in infection, while IE86 expression continues at
a high level. miR-UL112-1 may therefore be required to
achieve regulation of IE72 translation during acute replica-
tion and may be important to establish the correct kinetic
progress of viral gene expression. In support of this, a recent
publication by White et al. has demonstrated that over
expression of IE72 during acute replication correlates with a
drop in efﬁcient viral replication in ﬁbroblast cells [53].
Regulation of IE72 by miR-UL112-1 may also be important
for the establishment and maintenance of latent and
persistent infection in vivo [37]. Although studies on HCMV
latency are limited by the lack of effective tissue culture or
animal models, studies on the related murine cytomegalovi-
rus (MCMV) support a role for gene expression from the MIE
region during latent or persistent infections [57]. IE1 and IE3
of MCMV are thought to be the functional homologs of IE72
and IE86, respectively. Long-term expression of MCMV IE1 is
detected following establishment of a latent/persistent in-
fection in the lungs of mice, and immune escape of the virus
results in increased expression of IE3, which may represent
an initial step in reactivation. Since IE72 is required for
efﬁcient replication of the virus and promotes acute
replication by trans-activating early and late viral genes,
negative regulation by miR-UL112-1 could therefore poten-
tially contribute to establishing and maintaining a gene
expression pattern appropriate for latent or persistent
infection. Furthermore, c-herpesviruses express multiple
miRNAs during latent infection, suggesting a functional role
during this stage of viral infection [23,29]. Experiments to
determine the function role of IE72 regulation by miR-
UL112-1 are in progress.
Implications for the Function of Viral miRNAs
Given the relative complexity of gene expression in large
DNA viruses such as herpesviruses, the potential to regulate
multiple genes through a single miRNA is attractive. miRNAs
require minimal genomic space and are not thought to
induce innate or adaptive immune responses, a particularly
attractive characteristic for viruses that maintain long-term
infections of hosts. It is probable that additional herpesvirus
miRNAs are dedicated to the regulation of viral transcripts,
and it will be interesting to determine whether miRNAs
encoded by other viruses target major trans-activating genes
such as IE72. During the submission of this manuscript, a
recent study demonstrated that miR-UL112-1 also targets the
expression of the cellular gene MICB, a receptor for activated
natural killer cells. Interestingly, this would suggest that single
viral miRNAs have evolved the capacity to target both cellular
and viral gene expression [58].
Finally, the possibility that viral miRNAs may have evolved
as a mechanism to inhibit viral gene expression and viral
replication presents a particularly attractive avenue for
potential antiviral therapy strategies. Unlike many antivirals
that artiﬁcially block viral processes, delivery of endogenous
viral miRNAs could exploit the virus’s own mechanisms to
subdue replication. Not only might this approach be
effective, but it could also be less prone to the problems of
viral escape and resistance as the virus has evolved to
maintain these mechanisms.
Materials and Methods
Genome sequences. The annotated genome sequences for AD169
were downloaded from NCBI. Additional 39UTR sequences deleted
from AD169 were generated from the sequence of the HCMV clinical
strain TR genome. 39UTRs in the database consist of sequence from
the 39 end of each annotated ORF to the ﬁrst canonical AATAAA
polyadenylation sequence following that 39 end.
Target prediction. The online target prediction algorithm RNAhy-
brid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.
html) was used to identify potential target sites from the 39UTR
database [38]. The algorithm was run using default settings with the
additional constraints of full Watson Crick base pairing through
nucleotides2to7.ThepredictedmiRNAtargetbasepairingschematics
were produced using the online RNA folding program mfold (http://
frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin/rna-form1.cgi).
Cells, viruses, and reagents. Normal human dermal ﬁbroblast
(NHDF) cells (Clonetics) and human U373 cells (American Type
Culture Collection) were cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal calf serum and penicillin-
streptomycin-L-glutamine. HCMV strain AD169gfp was constructed
using the AD169 BAC genome [59]. In brief, the cellular EF1-a
promoter drives the gfp cassette and is inserted in the sense
orientation into the UL21.5 gene at nucleotide position 39389.
Plasmids. Luciferase reporter construct pMIR was acquired from
Ambion and was modiﬁed by replacing the ampicillin cassette with
the kanamycin cassette from pdsRED2-N1 vector (region 1874 to
2806) into the NotI and ScaI site of pMIR. Renilla ﬁreﬂy control
plasmid pRL was acquired from Promega. UL112/113, IE72, and IE86
39UTR sequences were cDNA cloned from RNA harvested from
HCMV-infected NHDF cells. Additional 39UTR sequences were
cloned directly from AD169 BAC DNA. Sequence coordinates as
follows: UL10 19598–20548; UL29i 31018–31466; UL29ii 28993–
29404; UL31 45826–46154; UL33 44399–46012; UL46 58472–58874;
UL47i 68421–68734; UL47ii 64519–64903; UL112/113 162801–162914;
UL114 160772–161167; UL120/121; IE72 170906–171005; IE86
169363–169275; US10 198659–199026. Genomic sequences were
cloned into SpeI and HindIII sites of the pMIR multiple cloning
region. The miRNA expression vector pSIREN was acquired from
Clontech. miR-UL112-1 and miR-UL22A-1 were PCR cloned directly
from AD169 BAC DNA, sequence coordinates miR-UL22A-1 27611–
27750; miR-UL112-1 163123–163321. pSVH-1 contains the genomic
region 168817–175524 of HCMV, which includes the MIE promoter
and exons encoding IE1 and IE2. The construction of this plasmid has
previously been described [41]. The pSVH-1 deletion mutant contains
a 39-base deletion between AD169 nucleotide coordinates 170968–
170912 and was constructed by site-directed mutagenesis. pSVH-1
IE2tar was constructed using site-directed mutagenesis. The pre-
dicted 21-base miR-UL112-1 target sequence from the 39UTR of IE72
was inserted at AD169 nucleotide coordinate 169336 of pSVH-1
deletion within the 39UTR coding sequence of IE2. The synthetic miR-
UL112-1RNA and negative control were purchased from Ambion.
Luciferase assays. Assays were conducted in a 96-well format. pMIR
constructs(0.2lg)wereco-transfectedinto293Tcellsalongwith0.2lg
miR-UL112-1 expression plasmid and 0.2 lg control renilla plasmid
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guidelines. Twenty-four hours post transfection, cells were harvested
and luciferase levels measured using the Dual luciferase reporter assay
system (Promega) according to the manufacturer’s guidelines.
Western blot analysis. Cells were lysed in buffer containing 50 mM
Tris (pH 8.0), 150 mM NaCl, 1% NP-40, and 1% sodium
deoxycholate. Proteins were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to
Immobilon-P membranes (Millipore). The following antibodies were
used: HCMV IE2 rabbit polyclonal antibody 638—antibody was
raised against the entire IE2 protein—and horseradish peroxidase
conjugated anti-rabbit (Amersham). Blots were visualized by Super-
signal West Pico chemiluminescent substrate (Pierce) according to
the manufacturer’s protocol.
Pre-miR transfection. U373 cells were transfected with pre-miR
RNAs using a modiﬁed version of the Oligofectamine protocol. A
20-lM stock (2.5 ll) of pre-miR was transfected into 24-well dishes of
U373 cells in Optimem media according to the manufacturer’s
guidelines. Cells were transfected three times and allowed to recover
for2hincompletemediabetweentransfections.Cellswereinfectedat
a multiplicity of 0.5 for 3 hs with AD169, then washed and overlayed
withfreshcompletemedia.Supernatantwasremovedandcellsharvest
in buffer containing 50 mM Tris (pH8.0), 150 mM NaCl, 1% NP-40,
and 1% sodium deoxycholate and subjected to western blot analysis.
RNA isolation and real-time RT-PCR. RNA was isolated from cells
using TRIzol Reagent (Invitrogen) according to the manufacturer’s
protocol. Total RNA (2 lg) was reverse transcribed using Omniscript
RT (Qiagen) and 1 lM random hexamer primers. One-tenth of the
RT reaction was used as a template for real-time PCR using TaqMan
Universal PCR master mix (Applied Biosystems) on an ABI prism
7700 Sequence detector. Sequences of primers and dual-labeled
TaqMan probes are IE86 forward primer ATGTCCTGGCA
GAACTCGGT; IE86 reverse primer GCTGCAAGAGTGGGTTGTCA;
IE86 probe VIC-CCAGTAGCACCGGCCCCACG-TAMRA; IE72 for-
ward primer AGTGACCGAGGATTGCAACG; IE72 reverse primer
CCTTGATTCTATGCCGCACC; IE72 probe VIC-AAAGAT
GTCCTGGCAGAACTCGTCAAACA-TAMRA.
Viral DNA quantiﬁcation by real-time PCR. DNA was isolated from
infectedcellsusingtheQia-AmpDNAisolationkit(Qiagen)according
to the manufacturer’s recommendations. Real-time PCR was carried
out using primers to the IE72 gene. Sequences of primers and dual-
labeled TaqMan probe are: forward primer TTACCGAGTTCTGC
CAGGACA; reverse primer CTGTTTCCAGAGTTGGCCGA; probe
VIC-TCTCGTTGCAATCCTCGGTCACTTGTT-TAMRA. Reactions
were carried out using TaqMan Universal PCR master mix (Applied
Biosystems) on an ABI prism 7700 Sequence detector.
Supporting Information
Figure S1. Northern Blot Analysis Showing Correct Expression of
Mature miR-UL112-1 from pSIREN Expression Construct
293T cells were transfected with pSIREN miR-UL112-1 using
Lipofectamine and RNA harvested 3 d post transfection. Lane 1,
pSIREN miR-UL112-1; lane 2, pLXSN miR-UL112-1 (construct not
used in this study); lane 3, RNA harvested from ﬁbroblast cells
infected with AD169 at an MOI of 5, 72 h post infection.
Found at doi:10.1371/journal.ppat.0030163.sg001 (2.4 MB AI).
Figure S2. Genomic Position and Predicted Binding between miR-
UL112-1 and Predicted Target Sequences in CCMV
(A) Genomic position of miR-UL112-1 targets sites within the MIE
region of CCMV. The MIE region showing IE72 and IE86 transcripts
resulting from alternative splicing are shown as well as splicing to
downstreamexonsUL120/UL121.PositionofmiR-UL112-1targetsites
in39UTRregionofIE72andUL120/UL121isindicatedbyredboxes.(B)
Predicted miR-UL112-1 binding to candidate CCMV target sites. Seed
region indicated by box surrounding nucleotide 2–6 of miRNA/target.
Found at doi:10.1371/journal.ppat.0030163.sg002 (200 KB AI).
Figure S3. Mutation of IE72 Target Site Effects miR-UL112-1-
Mediated Inhibition of IE72
A panel of mutations of the IE72 target site were constructed in the
context of pSVH-1 and tested for miR-UL112-1-mediated inhibition.
Panel of mutations is shown in Table S2. pSHV-1 constructs were co-
transfected with pSIREN UL112–1 or the pSIREN negative control
and IE86 and IE72 levels determined by western analysis. IE72 levels
shown as percentage of negative control following densitometry
analysis. Introduction of G:U base pairing within seed region did not
fully disrupt miR-UL112-1 inhibition of IE72 expression. Additional
mutations shown in Table S2 disrupted miR-UL112-1 inhibition of
IE72 expression.
Found at doi:10.1371/journal.ppat.0030163.sg003 (189 KB AI).
Figure S4. IE72 Expression from pSVH-1 Is Efﬁciently Inhibited by
pre-miR-UL112-1
pSVH-1 was co-transfected into U373 cells with either the synthetic
miR-UL112-1RNA or the random negative control pre-miR. Syn-
thetic miR-UL112-1 efﬁciently inhibits IE72 expression following co-
transfection with pSVH-1.
Found at doi:10.1371/journal.ppat.0030163.sg004 (234 KB AI).
Table S1. HCMV Transcripts Predicted to Contain Target Sequences
for miR-UL112-1
Target sequences were predicted using RNAhybrid and contain
targetsin both HCMVand the corresponding CCMV39UTRsequence.
Found at doi:10.1371/journal.ppat.0030163.st001 (46 KB DOC).
Table S2. MutationsofthemiR-UL112-1TargetSiteinthe39UTRofIE72
Seed sequence of wild-type target indicated in italics. Base
substitutions shown in bold.
Found at doi:10.1371/journal.ppat.0030163.st002 (26 KB DOC).
Accession Numbers
The National Center for Biotechnology Information (http://www.ncbi.
nlm.nih.gov/) annotated genome sequences discussed in this paper
are AD169 (X17403) and CCMV (NC_003521). Additional 39UTR
sequences deleted from AD169 were generated from the sequence of
the HCMV clinical strain TR genome (AC146906).
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